SCHEMBL20370511

SCHEMBL20370511

C=CC(=O)N(C)C1CCC(c2ccc(-c3ccc(C4CCC(CCCCC)CC4)cc3)c(F)c2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FASN P49327 1/20 0.45
▸ CYP2C9 P11712 3/20 0.39
▸ CYP3A4 P08684 3/20 0.39
▸ APP P05067 2/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ BTK Q06187 6/20 0.36
▸ LSS P48449 1/20 0.35
▸ SPHK1 Q9NYA1 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ RARB P10826 1/20 0.35
▸ ABCB11 O95342 1/20 0.35
▸ EGFR P00533 1/20 0.35
▸ ERBB2 P04626 1/20 0.35
▸ TEC P42680 1/20 0.35
▸ TXK P42681 1/20 0.35
▸ BLK P51451 1/20 0.35
▸ BMX P51813 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20370509 1.00 FASN (0.45) FASNCYP2C9CYP3A4APPCYP2D6
SCHEMBL19854627 0.92 FASN (0.41) FASNCYP2C9CYP3A4APPCYP2D6
SCHEMBL20370510 0.90 CYP2C9 (0.36) FASNCYP2C9CYP3A4BTKLSS
SCHEMBL20370513 0.90 CYP2C9 (0.36) FASNCYP2C9CYP3A4APPCYP2D6
SCHEMBL20370504 0.88 CYP2C9 (0.43) FASNCYP2C9LSSSPHK1ALDH1A1
SCHEMBL19854467 0.87 CYP2C9 (0.45) CYP2C9LSSSPHK1ALDH1A1LMNA
SCHEMBL19854091 0.85 LSS (0.35) FASNCYP2C9BTKLSSSPHK1
SCHEMBL20370491 0.85 LSS (0.35) FASNCYP2C9BTKLSSSPHK1
SCHEMBL19853827 0.85 LSS (0.35) FASNCYP2C9BTKLSSSPHK1
SCHEMBL20370498 0.85 LSS (0.35) FASNCYP2C9BTKLSSSPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 — — US disclosed
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 — — US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 — — US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, MBD2, PAXBP1 FASN 2702/4885CYP2C9 3761/4885CYP3A4 1930/4885
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device SP1, MBD2, PAXBP1 FASN 2702/4885CYP2C9 3761/4885CYP3A4 1930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback